Drug Shortages and Curative Cancer Therapy: The Problem of Dacarbazine and Classical Hodgkin's Lymphoma

JCO Oncol Pract. 2022 Jul;18(7):499-500. doi: 10.1200/OP.22.00161. Epub 2022 Apr 14.

Authors

Nicole Soriano¹, Kate Berlin¹, Leo I Gordon²

Affiliations

¹ Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL.
² Division of Hematology/Oncology, the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.

PMID: 35420909
DOI: 10.1200/OP.22.00161

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Dacarbazine / pharmacology
Dacarbazine / therapeutic use
Hodgkin Disease* / drug therapy
Hodgkin Disease* / pathology
Humans

Substances

Dacarbazine